553PBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by t... von Gramont, A De, Henriques, J, Baruch, B, Kim, T W, Martinez-Villacampa, M, Gallego-Plazas, J, Cervantes, A, Shim, K, Jonker, D J, Guerin-Meyer, V, Mineur, L, Banzi, M, Dewdney, A, Dejthevaporn, T Sirisingha, Bloemendal, H J, Roth, A D, Thompson, P, Moehler, M, Aguilar, E Aranda, André, T

Volltext

553P - Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial b... von De Gramont, A., Henriques, J., Baruch, B., Kim, T.W., Martinez-Villacampa, M., Gallego-Plazas, J., Cervantes, A., Shim, K., Jonker, D.J., Guerin-Meyer, V., Mineur, L., Banzi, M., Dewdney, A., Dejthevaporn, T Sirisingha, Bloemendal, H.J., Roth, A.D., Thompson, P., Moehler, M., Aguilar, E Aranda, André, T.

Volltext

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the G... von De Gramont, A., Henriques, J., Baruch, B., Kim, T.W., Martinez-Villacampa, M., Gallego-Plazas, J., Cervantes, A., Shim, K., Jonker, D.J., Guerin-Meyer, V., Mineur, L., Banzi, M., Dewdney, A., Dejthevaporn, T Sirisingha, Bloemendal, H.J., Roth, A.D., Thompson, P., Moehler, M., Aguilar, E Aranda, André, T.

Volltext